u/hassan_ostergaard

Push back: that is not a plateau, that is maintenance. You have arrived and you are describing it as a failure.

Not convinced. You changed the dose and the week at the same time, so you cannot attribute the change to either.

the peripheral and central stories are not in competition

Disagreeing with this specific inference — that is a preclinical result being read as human pharmacology.

Correction: 17kg over 12 months is a different claim from 17kg in a month, and the post reads as the second.

Are we talking about receptor affinity or clinical potency?

That study was in a rodent model. Worth stating, since the thread has been reading it as human data.

Correct, and worth adding: the trial average is an average. Half the people in it did worse than 15% and were still on the drug.

dose for glycaemic control is not the same conversation as dose for weight

Small fix — insulin secretion in this class is glucose-dependent, which is precisely why the risk you describe comes from the other agent.

Right, and the hair thing is worth repeating: it tracks the rate of loss rather than the compound, and it stops.

waist is the measurement that keeps moving during a scale stall

stretching the interval is not the same as reducing the dose

Purity methods differ by compound class. A gradient and wavelength developed for one peptide will not necessarily resolve the relevant impurities of another.

Same. Monthly is plenty at this stage and daily weighing made me miserable for no information gain.

Has anything else changed in the same window?

Small fix — it slows gastric emptying, it does not halt it, and the distinction matters for the mechanism you are proposing.

Wrote down what maintenance would look like at about week 78, before I needed it. Having decided in advance made the transition boring.

That method was developed for a different compound class and would not resolve the impurities you are asking about.

Minor fix — the half-life is about a week, not about a day.

Right, and the timescale is the bit that keeps getting lost. Judge a step at a month, not at a weekend.

Disagree. Severe abdominal pain is not on the list of things to wait out, and this board should not be treating it as one.

Agreed that goal weights picked at the start are guesses. Mine was, and I revised it twice.

That reads like a taper schedule and this board cannot hand those out.

The diabetes and obesity programmes are separate, with different populations and different primary endpoints. Reading a result across from one to the other is not a comparison.

Is the goal you set at the start still the goal?

I would not treat a two-kilo range as a regain. Weight varies day to day in everybody.

Same pattern here.

step_therapy_s is right about the timing. The day-of-week pattern is the diagnostic bit, not the severity.

This matches me almost exactly, right down to the early fullness showing up on the second day and being gone by the fourth.

Yes. The starting dose is a tolerance step. It is not supposed to do very much.

Nothing in this thread is medical advice, including this comment. I am describing a mechanism, not telling anybody what to do about their own week.

The fatigue turned out to be that I was eating about a third of what I thought I was. Tracked it for a week and the mystery evaporated.

boring is the objective now

Body weight varies by a couple of kilos over days in stable people through fluid, glycogen and gut content. A range is not a trend.

The half-life explanation was the thing that made weekly dosing intuitive for me rather than arbitrary.

Did protein intake change in the same window?

Long half-life in this class comes from structural modification that promotes albumin binding and resists enzymatic degradation. Weekly dosing is a consequence of the molecule, not a convenience decision.

Has anything else changed in the same window?

sulphur burps are unpleasant and they are not dangerous

Cosigning. The appetite change and the scale change ran about three weeks apart for me too.